No matter how old you are, if you take one of these medications, lifestyle habits should be incorporated into your life
All references FDA: Concerns with unapproved GLP-1 drugs used for weight loss NEJM (2023): Retatrutide Phase 2 trial in obesity Eli Lilly: Phase 2 retatrutide results published in NEJM Eli Lilly (Dec 2025): Phase 3 TRIUMPH-4 topline results announcement ClinicalTrials.gov: NCT05882045 (TRIUMPH-3) Drugs.com: Retatrutide status & timeline Lilly Trials: TRIUMPH-3 summary page
You can work out your own ratio with the AST:ALT ratio calculator
Sometimes teens on GLP-1s can develop a rash or hives, which I have not seen in adults
Razia Hashmi, the associations vice president of clinical affairs
The primary outcomes of the study were changes in HbA1c, body weight, and FPG from baseline, while safety outcomes were selected as secondary outcomes